Mutation and structure guided discovery of an antiviral small molecule that mimics an essential C-Terminal tripeptide of the vaccinia D4 processivity factor
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 162, 178-185
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (SBIR-1R44AI115759)
This publication has 39 references indexed in Scilit:
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- Identification of Protein-Protein Interaction Inhibitors Targeting Vaccinia Virus Processivity Factor for Development of Antiviral AgentsAntimicrobial Agents and Chemotherapy, 2011
- Evaluation of the Role of the Vaccinia Virus Uracil DNA Glycosylase and A20 Proteins as Intrinsic Components of the DNA Polymerase HoloenzymeJournal of Biological Chemistry, 2011
- Swimming into peptidomimetic chemical space using pepMMsMIMICNucleic Acids Research, 2011
- Identification of Inhibitors that Block Vaccinia Virus Infection by Targeting the DNA Synthesis Processivity Factor D4Journal of Medicinal Chemistry, 2011
- Target identification using drug affinity responsive target stability (DARTS)Proceedings of the National Academy of Sciences of the United States of America, 2009
- Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approachAntiviral Research, 2008
- Identification of Non-Nucleoside DNA Synthesis Inhibitors of Vaccinia Virus by High-Throughput ScreeningJournal of Medicinal Chemistry, 2008
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004